Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287867 · ClinicalTrials.gov registry record · NA
Trial for Treating Painful Degenerative Disc Disease
A NA study of Degenerative Disc Disease, sponsored by Regenexx.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 2
- Study locations
NCT05287867 is a NA study of Degenerative Disc Disease that is actively recruiting participants, run by Regenexx. The registered enrollment target is 42 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05287867, a NA study of Degenerative Disc Disease, is actively recruiting participants, sponsored by Regenexx.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.
Conditions Studied
Interventions
- BIOLOGICAL Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP)
- OTHER Sham procedure
Study Locations (2)
Colorado
- Centeno-Schultz Clinic - Broomfield
- Centeno-Schultz Clinic - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-05-06 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287867
The ClinicalTrials.gov registry entry for NCT05287867 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (75% lower). The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP) is the first listed.
NCT05287867 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05287867 about?
NCT05287867 is a clinical study titled "Trial for Treating Painful Degenerative Disc Disease". To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.
What is the current status of trial NCT05287867?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2022-05-06. Estimated completion is 2026-12-31.
What conditions does trial NCT05287867 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT05287867?
The interventions under investigation include: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP) (BIOLOGICAL), Sham procedure (OTHER).
Who is sponsoring clinical trial NCT05287867?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287867 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
-
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.